Market Tracker

02/21 4:28pm ET

Novo Nordisk A/S (NYSE:NVO)

35.37
Delayed Data
As of 4:02pm ET
 -0.09 / -0.25%
Today’s Change
30.89
Today|||52-Week Range
57.81
-1.37%
Year-to-Date

Today’s Trading

Previous close35.46
Today’s open35.22
Day’s range35.20 - 35.46
Volume2,385,067
Average volume (3 months)3,718,394
Market cap$69.5B
Dividend yield3.75%
Data as of 4:02pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+3.81%
P/E ratio2.4
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.15-0.51%
ABTAbbott Laboratories+0.32+0.72%
SHPGShire-0.43-0.24%
LLYEli Lilly and Co-0.03-0.04%
Data as of 4:02pm ET, 02/21/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts